נולוג'יקס 250 מ"ג

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Nunua Sasa

Viambatanisho vya kazi:

BELATACEPT 25 MG/ML

Inapatikana kutoka:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC kanuni:

L04AA28

Dawa fomu:

POWDER FOR CONCENTRATE FOR INFUSION

Njia ya uendeshaji:

I.V

Viwandani na:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Kundi la matibabu:

BELATACEPT

Matibabu dalili:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Idhini ya tarehe:

2012-08-01

Tafuta arifu zinazohusiana na bidhaa hii